Delivery Order SPE2D021DA002-SPE2D324F059P

Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $4K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of 4,565,118,241 units of the TWINRIX vaccine syringe. The contract has an ultimate completion date of July 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the TWINRIX vaccine in syringes. The contract, valued at $2,454.93, has a performance period through May 15, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and DLA under the SPE2DB program, which enables the agency to order a range of pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,454.93, is for the delivery of 4,568,085,986 units of the TWINRIX vaccine syringe by May 1, 2025. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
This federal contract award, valued at $3,205.84, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of TWINRIX VACCINE SYRINGE, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The contract is a delivery order under a larger indefinite delivery contract (IDC) valued at up to $499,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of TWINRIX VACCINE SYRINGE and has a completion date of June 21, 2024. DMS Pharmaceutical Group Inc. holds a separate, larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to the woman-owned small business DMS Pharmaceutical Group Inc. The contract, valued at $1,602.92, is for the delivery of the TWINRIX vaccine syringe. This award is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued up to $499,999,999, which provides a wide range of pharmaceutical products to support military medical...
This is a $8,014.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of TWINRIX vaccine syringes to support the medical supply needs of military healthcare facilities. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of TWINRIX vaccine syringes, with a ceiling value of $1,602.92 and a period of performance through July 5, 2024. This award is not associated with a set-aside program. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the TWINRIX vaccine in syringe form, with a ceiling value of $24,549.30 and an ultimate completion date of May 28, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of TWINRIX vaccine syringes to the DLA. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, to provide a comprehensive range of pharmaceutical items to...
  • SPE2D021DA002
    Indefinite Delivery Contract
  • SPE2D021DA002-SPE2D324F059P
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the TWINRIX vaccine syringe, with a ceiling value of $4,007.30 and a period of performance through June 20, 2024.

The contract is a delivery order issued under a larger indefinite delivery contract (IDC) with the DLA's Medical Supply Chain division, valued at up to $499,999,999 and running through December 31, 2025. This single-award IDC allows the DLA to place firm fixed-price delivery orders for a wide range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation.

Through this and other prime vendor contracts, DMS Pharmaceutical Group provides a comprehensive array of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA), supporting the diverse medical requirements of military personnel and their dependents across various DoD healthcare facilities.

Generated 9/17/24, 9:38 AM